---
sidebar_position: 2
---

# Χ‘Χ—Χ™ΧΧ•Χ Χ•Χ”Χ§ΧΧ•Χ
## Nausea and Vomiting

## ΧΧ‘Χ•Χ

Χ Χ™Χ”Χ•Χ Χ”ΧΧ™Χ¤Χ•Χ Χ‘Χ‘Χ—Χ™ΧΧ•Χ Χ•Χ”Χ§ΧΧ•Χ Χ‘ΧΧΧ•Χ¤ΧΧ™Χ Χ¤ΧΧ™ΧΧΧ™Χ‘Χ™Χ™Χ Χ™Χ›Χ•Χ ΧΧ”Χ™Χ•Χ ΧΧ•Χ¨Χ›Χ‘ Χ‘Χ©Χ Χ’Χ•Χ¨ΧΧ™Χ Χ¤Χ•ΧΧ Χ¦Χ™ΧΧΧ™Χ™Χ ΧΧ¨Χ•Χ‘Χ™Χ ΧΧΧ΅ΧΧ™Χ Χ‘Χ›Χ ΧΧΧ•Χ¤Χ. Χ™Χ© ΧΧ§Χ•Χ ΧΧΧΧ¥ Χ’Χ™Χ©Χ” ΧΧ§Χ‘Χ™ΧΧ” ΧΧ–Χ• Χ”Χ Χ”Χ•Χ’Χ” Χ‘Χ Χ™Χ”Χ•Χ Χ›ΧΧ‘ Χ‘Χ¤ΧΧ™ΧΧ¦Χ™Χ” Χ•ΧΧ‘Χ—Χ•Χ ΧΧ Χ”Χ¨ΧΆΧ™Χ•Χ Χ©Χ β€Total Nauseaβ€.

## ΧΧ•ΧΧ“Χ
-   Χ¨Χ§ΧΆ Χ¨Χ¤Χ•ΧΧ™ - ΧΧ©ΧΧ•Χ Χ Χ¤Χ¨Χ“ ΧΧ‘Χ—Χ™ΧΧ•Χ Χ•ΧΧ”Χ§ΧΧ•Χ:
    - ΧΧ¨Χ™Χ’Χ¨Χ™Χ, Χ Χ¤Χ—, Χ“Χ¤Χ•Χ΅
    - Χ’Χ•Χ¨ΧΧ™Χ ΧΧ—ΧΧ™Χ¨Χ™Χ Χ•ΧΧ§ΧΧ™Χ, Χ›Χ•ΧΧ ΧΧ¨Χ•Χ¤Χ•Χ Χ©Χ Χ™ΧΧ Χ•, Χ‘Χ•Χ“Χ“Χ•Χ ΧΧ• Χ©Χ™ΧΧ•Χ‘ Χ•Χ¦Χ•Χ¨Χ•Χ Χ”ΧΧΧ Χ©Χ Χ•Χ΅Χ•
    - Χ”Χ¨Χ’ΧΧ™ Χ¤ΧΆΧ•ΧΧ ΧΧΆΧ™Χ™Χ
    - ΧΧ¨Χ•Χ¤Χ•Χ - ΧΧ§Χ—Χ Χ‘Χ—Χ©Χ‘Χ•Χ ΧΧ¨Χ•Χ¤Χ•Χ Χ©ΧΆΧ©Χ•Χ™Χ•Χ:
        - ΧΧΧ¨Χ•Χ ΧΧΧ—Χ•Χ©Χ Χ‘Χ—Χ™ΧΧ” Χ•Χ”Χ§ΧΧ”
        - ΧΧ’Χ¨Χ•Χ Χ Χ–Χ§
        - ΧΧ ΧΧ”Χ©Χ¤Χ™ΧΆ Χ‘Χ©Χ Χ‘Χ—Χ™ΧΧ” Χ•Χ”Χ§ΧΧ”
    - ΧΧ©ΧΧ•Χ Χ¨Χ’Χ•Χ¨Χ’Χ™ΧΧ¦Χ™Χ” Χ©Χ›Χ Χ”Χ™Χ ΧΧ¦Χ¨Χ™Χ›Χ” Χ’Χ™Χ©Χ” Χ©Χ•Χ Χ”. ΧΧ Χ§Χ™Χ™Χ Χ—Χ©Χ“ ΧΧ›Χ, Χ™Χ© ΧΧ”Χ™Χ•Χ•ΧΆΧ¥ ΧΆΧ Χ’Χ•Χ¨Χ ΧΧΧΧ™Χ.
    - ΧΧ‘Χ“Χ•Χ§ Χ”Χ™ΧΧ¦ΧΧ•Χ ΧΧ΅ΧΧ™Χ Χ™Χ Χ ΧΧ•Χ•Χ™Χ.
-   Χ‘Χ“Χ™Χ§Χ” Χ’Χ•Χ¤Χ Χ™Χ:
    - ΧΧ™ΧΧ•Χ¨ Χ΅Χ™ΧΧ Χ™ Χ”ΧΧ™Χ™Χ‘Χ©Χ•Χ, Χ΅Χ¤Χ΅Χ™Χ΅ ΧΧ• Χ”Χ¨ΧΆΧΧ ΧΧ¨Χ•Χ¤Χ•Χ. 
    - ΧΧΆΧ¨Χ›Χ ΧΆΧ¦Χ‘Χ™Χ ΧΧ¨Χ›Χ–Χ™Χ.
    - Χ‘ΧΧ. ΧΧ“Χ•Χ’ΧΧ”: Χ”Χ’Χ“ΧΧ ΧΧ‘Χ¨Χ™Χ (ΧΧ•Χ¨Χ’Χ Χ•ΧΧ’ΧΧ™Χ”), Χ§Χ•ΧΧ•Χ ΧΧΆΧ™ ,succussion splash  *(Χ¦ΧΧ™Χ Χ©Χ Χ”ΧΧ–Χ ΧΧ™Χ Χ‘Χ”ΧΧ–Χ Χ” Χ©Χ™Χ›Χ•Χ ΧΧ”ΧΆΧ™Χ“ ΧΆΧ Χ”Χ¦ΧΧ‘Χ¨Χ•Χ Χ Χ•Χ–Χ Χ‘Χ§Χ™Χ‘Χ” Χ•Χ—Χ΅Χ™ΧΧ ΧΧ•Χ¦Χ Χ”Χ§Χ™Χ‘Χ”). 
    - Χ—Χ•Χ Χ’Χ•Χ£, Χ“Χ•Χ¤Χ§ Χ•Χ Χ©Χ™ΧΧ”.
-   Χ‘Χ“Χ™Χ§Χ•Χ Χ“Χ Χ‘Χ›Χ¤Χ•Χ£ Χ•Χ”ΧΧΧΧ” ΧΧΧ¦Χ‘ Χ”Χ—Χ•ΧΧ” Χ•ΧΧΧ¨Χ•Χ Χ”ΧΧ™Χ¤Χ•Χ:
    - ΧΧ•Χ¨ΧΧ” Χ•ΧΧΧ§ΧΧ¨Χ•ΧΧ™ΧΧ™Χ
    - ΧΧ¤Χ§Χ•Χ“Χ™ Χ›Χ‘Χ“
    - Χ¨ΧΧ•Χ Χ΅Χ™Χ“Χ
    - Χ’ΧΧ•Χ§Χ•Χ– Χ‘Χ“Χ
-   ΧΧ©ΧΧ•Χ Χ–Χ™Χ”Χ•Χ Χ‘Χ“Χ¨Χ›Χ™ Χ”Χ©ΧΧ

## ΧΧΧ•Χ Χ” Χ§ΧΧ™Χ Χ™Χ
**ΧΧ¨Χ—Χ™Χ©Χ™Χ Χ§ΧΧ™Χ Χ™Χ™Χ Χ¤Χ•ΧΧ Χ¦Χ™ΧΧΧ™Χ™Χ**

**1.	Χ¨ΧΆΧ™ΧΧ•Χ Χ§ΧΧ™Χ Χ™Χ (Χ›Χ•ΧΧ ΧΧ’Χ•Χ¨Χ ΧΧ¨Χ•Χ¤ΧΧ™) ΧΧ• Χ”Χ¤Χ¨ΧΆΧ” ΧΧΧ‘Χ•ΧΧ™Χ / Χ‘Χ™Χ•Χ›Χ™ΧΧ™Χ (Χ’Χ™Χ¨Χ•Χ™ Χ©Χ CTZ β€“ chemoreceptor trigger zone)**  

**2.	Χ”Χ¤Χ¨ΧΆΧ” Χ‘Χ Χ™ΧΆ (ΧΧ•ΧΧ™ΧΧ™Χ•Χ)**  


**3. Χ”Χ¤Χ¨ΧΆΧ•Χ ΧΧ•Χ Χ’Χ•ΧΧ’Χ•ΧΧΧ™Χ•Χ, ΧΧΧ©Χ: ΧΧ—Χ¥ ΧΧ•Χ Χ’Χ•ΧΧ’Χ•ΧΧΧ™ ΧΧ•Χ’Χ‘Χ¨, ΧΧ™ ΧΧ¤Χ§Χ•Χ“ Χ•Χ΅ΧΧ™Χ‘Χ•ΧΧ¨Χ™, Χ‘Χ—Χ™ΧΧ” Χ”Χ§Χ©Χ•Χ¨Χ” ΧΧΧ Χ•ΧΆΧ”.**  

**4.	Χ’Χ™Χ¨Χ•Χ™ Χ¤Χ” / ΧΧ•ΧΆ / Χ•Χ©Χ**  

**5. Χ¨Χ‘ Χ΅Χ™Χ‘ΧΧ™ / ΧΧ Χ™Χ“Χ•ΧΆ / ΧΆΧΧ™Χ“ (refractory)**  
ΧΧ™Χ¤Χ•Χ:
-   Χ”ΧΆΧ¨Χ›Χ Χ΅Χ™Χ‘Χ•Χ ΧΧ¤Χ©Χ¨Χ™Χ•Χ ΧΧ΅ΧΧ¤ΧΧ•Χ Χ•ΧΧ™Χ¤Χ•Χ Χ‘Χ”ΧΧΧ. ΧΧ Χ”Χ‘Χ—Χ™ΧΧ•Χ Χ•Χ”Χ”Χ§ΧΧ•Χ Χ ΧΧ©Χ›Χ•Χ, Χ©Χ™ΧΧ•Χ© Χ‘-  LEVOMEPROMAZINE  Χ›Χ Χ•Χ’Χ“ Χ”Χ§ΧΧ” Χ¨Χ—Χ‘ ΧΧ•Χ•Χ—.LEVOMEPROMAZINE<sup>QT</sup> (Nozinan) (Ronexine)  Χ‘ΧΧ™Χ Χ•Χ  3mg - 6mg Χ‘ΧΧΧ Χ¤Χ•ΧΧ™ Χ¤ΧΆΧΧ™Χ™Χ Χ‘Χ™Χ•Χ, ΧΧ• Χ‘ΧΧΧ ΧΧ ΧΆΧ•Χ¨Χ™<sup>QT,OL</sup> Χ‘ΧΧ™Χ Χ•Χ 2.5mg - 5mg ΧΧ¤Χ™ Χ”Χ¦Χ•Χ¨Χ Χ›Χ 12 Χ©ΧΆΧ•Χ, ΧΧ•  5mg - 15mg ΧΧΧ©Χ 24 Χ©ΧΆΧ•Χ Χ“Χ¨Χ ΧΆΧ™Χ¨Χ•Χ™ ΧΧ ΧΆΧ•Χ¨Χ™ ΧΧΧΧ©Χ. Χ™ΧΧ›Χ Χ©Χ™Χ”Χ™Χ” Χ¦Χ•Χ¨Χ Χ‘ΧΧΧ ΧΧ›Χ•Χ£ Χ™Χ•ΧΧ¨ Χ©Χ Χ–Χ¨Χ™Χ§Χ•Χ ΧΧ ΧΆΧ•Χ¨Χ™Χ•Χ Χ‘ΧΧ—Χ™ΧΧ Χ”ΧΧ™Χ¤Χ•Χ, ΧΧΧ©Χ Χ›Χ Χ©ΧΆΧ”, Χ›Χ“Χ™ ΧΧ”Χ’Χ™ΧΆ ΧΧ©ΧΧ™ΧΧ” Χ‘Χ΅Χ™ΧΧ¤ΧΧ•Χ. Χ™Χ© ΧΧ©Χ§Χ•Χ ΧΧ§Χ•Χ¨ ΧΧ¨Χ›Χ–Χ™ Χ’Χ‘Χ•Χ” Χ™Χ•ΧΧ¨ Χ›Χ’Χ•Χ: Χ›ΧΧ‘, Χ¤Χ—Χ“, Χ—Χ¨Χ“Χ”.

Χ‘ΧΧ Χ”ΧΧ΅ΧΧ™Χ ΧΆΧ™Χ§Χ©, Χ™Χ© ΧΧ¤Χ Χ•Χ ΧΧ™ΧΆΧ•Χ¥ ΧΧ•ΧΧ—Χ”. 

**6. ΧΧ§Χ•Χ¨ ΧΧ¨Χ›Χ–Χ™ Χ’Χ‘Χ•Χ” (Χ›ΧΧ‘ / Χ¤Χ—Χ“ / Χ—Χ¨Χ“Χ”)**  
ΧΧ™Χ¤Χ•Χ:
-   Χ”ΧΆΧ¨Χ›Χ” Χ•Χ”ΧΧΆΧ¨Χ‘Χ•Χ ΧΆ"Χ¤ ΧΧ•ΧΧ“Χ Χ•ΧΧ™Χ¤Χ•Χ Χ‘Χ›ΧΧ‘.
-   Χ‘Χ—Χ™ΧΧ” ΧΧΧ¨Χ™ΧΧ” (anticipation) ΧΧ• Χ—Χ¨Χ“Χ” ΧΆΧ©Χ•Χ™Χ•Χ ΧΧ”Χ’Χ™Χ‘ ΧΧ‘Χ Χ–Χ•Χ“Χ™ΧΧ–Χ™Χ¤Χ™Χ Χ™Χ, Χ›Χ’Χ•Χ LORAZEPAM (Lorivan)  Χ‘ΧΧ™Χ Χ•Χ  0.5mg - 1mg ΧΧ ΧΧ©Χ•Χ Χ™, ΧΧ• DIAZEPAM (Assival) Χ¤Χ•ΧΧ™ Χ‘ΧΧ™Χ Χ•Χ 2mg - 5mg. 

Χ‘ΧΧ Χ”ΧΧ΅ΧΧ™Χ ΧΆΧ™Χ§Χ©, Χ™Χ© ΧΧ¤Χ Χ•Χ ΧΧ™ΧΆΧ•Χ¥ ΧΧ•ΧΧ—Χ”. 


## ΧΧ™Χ¤Χ•Χ
**ΧΆΧ¦Χ•Χ Χ›ΧΧΧ™Χ•Χ**
-	ΧΧ¤Χ Χ‘Χ΅Χ™Χ‘Χ•Χ Χ”Χ¤Χ™Χ›Χ•Χ ΧΧ Χ Χ™ΧΧ.
-	Χ Χ΅Χ” ΧΧ™Χ™ΧΆΧ ΧΧ Χ”ΧΧ™Χ¤Χ•Χ Χ”Χ§Χ™Χ™Χ (ΧΧ¨Χ•Χ¤ΧΧ™ Χ•Χ©ΧΧ™Χ Χ• ΧΧ¨Χ•Χ¤ΧΧ™ Χ›ΧΧ—Χ“)
-	Χ”Χ›Χ¨ Χ‘Χ¤Χ—Χ“Χ™Χ Χ•Χ‘Χ—Χ¨Χ“Χ•Χ Χ•Χ΅Χ¤Χ§ ΧΧ™Χ¤Χ•Χ ΧΧ•ΧΧ ΧΧΧΧ™Χ. ΧΧ“Χ•Χ’ΧΧ- Χ”Χ¦ΧΆ Χ”Χ΅Χ‘Χ¨ ΧΆΧ Χ”Χ΅Χ™ΧΧ¤ΧΧ•ΧΧ™Χ Χ•ΧΧ™Χ“ΧΆ Χ›ΧΧ•Χ‘.
-	ΧΧΧ§Χ ΧΧ Χ©Χ Χ™ΧΧ ΧΧΧ™Χ§Χ•Χ (ΧΧ“Χ•Χ’ΧΧ ΧΧ¤Χ§Χ•Χ“ Χ›ΧΧ™Χ™ΧΧ™, Χ”Χ™Χ¤Χ¨Χ§ΧΧ¦ΧΧ™Χ”, Χ”Χ™Χ¤Χ•Χ ΧΧ¨ΧΧ™Χ”, Χ”Χ™Χ¤Χ¨Χ’ΧΧ™Χ§ΧΧ™Χ”, ΧΆΧ¦Χ™Χ¨Χ•Χ, ΧΧ™Χ™ΧΧ Χ΅Χ™ΧΧ¤ΧΧ•ΧΧΧ™Χ, Χ‘Χ¦Χ§Χ ΧΧ•Χ—Χ™Χ / ΧΧ—Χ¥ ΧΧ•Χ Χ’Χ•ΧΧ’ΧΧΧ™ ΧΧ•Χ’Χ‘Χ¨, Χ΅Χ§Χ™Χ¨Χ ΧΧ¨Χ•Χ¤Χ•Χ)
-	ΧΧ©Χ§Χ•Χ ΧΧ™Χ¤Χ•Χ Χ‘ΧΧΧ¦ΧΆΧ™Χ ΧΧ ΧΧ¨Χ•Χ¤ΧΧ™Χ™Χ (Χ¨ΧΧ• ΧΧ”ΧΧ Χ”ΧΧΆΧ¨Χ‘Χ•Χ™Χ•Χ ΧΧ ΧΧ¨Χ•Χ¤ΧΧ™Χ•Χ).
-	ΧΧ‘Χ—Χ•Χ¨ Χ Χ•Χ’Χ“ Χ”Χ§ΧΧ” Χ”ΧΧΧΧ™Χ ΧΧ’Χ•Χ¨Χ Χ”ΧΧ©Χ•ΧΆΧ¨.
-	ΧΧΆΧΧ™Χ ΧΧΧΧ™Χ ΧΧ©ΧΧ‘ ΧΧ΅Χ¤Χ¨ Χ Χ•Χ’Χ“Χ™ Χ”Χ§ΧΧ”.
-	ΧΧ”Χ©ΧΧΧ© Χ‘Χ Χ•Χ’Χ“ Χ”Χ§ΧΧ” Χ¨Χ—Χ‘ ΧΧ•Χ•Χ— Χ›ΧΧ©Χ¨ ΧΧΆΧ•Χ¨Χ‘Χ™Χ ΧΧ΅Χ¤Χ¨ Χ’Χ•Χ¨ΧΧ™Χ Χ‘Χ•-Χ–ΧΧ Χ™Χ.
-	Χ©Χ™ΧΧ•Χ‘ ΧΧ™Χ¤Χ•Χ Χ ΧΧ•Χ•Χ” Χ‘Χ§Χ•Χ¨ΧΧ™Χ§Χ•Χ΅ΧΧ¨Χ•ΧΧ™Χ“Χ™Χ Χ•/ΧΧ• Χ‘Χ Χ–Χ•Χ“Χ™ΧΧ–Χ¤Χ™Χ Χ™Χ Χ™Χ—Χ“ ΧΆΧ Χ Χ•Χ’Χ“Χ™ Χ”Χ§ΧΧ”.
-	Χ™Χ© ΧΧ”Χ©ΧΧ“Χ ΧΧ”Χ™ΧΧ ΧΆ ΧΧ¨Χ™Χ©Χ•Χ ΧΧ¨Χ•Χ¤Χ•Χ Χ¤Χ¨Χ•Χ§Χ™Χ ΧΧ™Χ•Χ (ΧΧΧ©Χ METOCLOPRAMIDE<sup>QT</sup>) Χ™Χ—Χ“ ΧΆΧ ΧΧ¨Χ•Χ¤Χ•Χ ΧΧ ΧΧ™Χ›Χ•ΧΧ™Χ Χ¨Χ’Χ™Χ•Χ (ΧΧΧ©Χ CYCLIZINE) Χ‘Χ•-Χ–ΧΧ Χ™Χ. Χ”ΧΧ ΧΧ™Χ›Χ•ΧΧ™Χ Χ¨Χ’Χ™Χ•Χ ΧΧ¤Χ—Χ™ΧΧ•Χ ΧΧ Χ”Χ©Χ¤ΧΆΧ Χ”Χ¤Χ¨Χ•Χ§Χ™Χ ΧΧ™Χ•Χ.
-	Χ‘Χ‘Χ—Χ™Χ¨Χ Χ¦Χ•Χ¨Χ Χ”ΧΧΧ Χ”ΧΧ¨Χ•Χ¤ΧΧ™Χ Χ”ΧΧΧΧ™ΧΧ” Χ™Χ© ΧΧ”ΧΧ—Χ©Χ‘ Χ‘:
    - <sup>π”―</sup>Χ”Χ΅Χ¤Χ™Χ’Χ” Χ•Χ”Χ–ΧΧ™Χ Χ•Χ Χ”Χ‘Χ™Χ•ΧΧ•Χ’Χ™Χ Χ‘ΧΧΧ Χ¤Χ•ΧΧ™ ΧΆΧΧ•ΧΧ” ΧΧ”Χ™Χ¤Χ’ΧΆ ΧΆΧ§Χ‘ Χ‘Χ—Χ™ΧΧ” (ΧΧΆΧ›Χ‘Χ ΧΧ Χ¨Χ™Χ§Χ•Χ Χ”Χ§Χ™Χ‘Χ”) ΧΧ• Χ”Χ§ΧΧ Χ”ΧΧ¨Χ•Χ¤Χ”.
    - ΧΧΧ Χ‘Χ•Χ§ΧΧΧ™ (ΧΧ—Χ™) ΧΧ• ΧΧ ΧΧ©Χ•Χ Χ™ Χ™Χ›Χ•Χ ΧΧ”Χ™Χ•Χ Χ™ΧΆΧ™Χ ΧΧ ΧΆΧ©Χ•Χ™ ΧΧΆΧ•Χ¨Χ¨ Χ‘ΧΆΧ¦ΧΧ• Χ‘Χ—Χ™ΧΧ” Χ•Χ”Χ§ΧΧ” Χ‘ΧΧ Χ©Χ™Χ Χ¨Χ’Χ™Χ©Χ™Χ.
    - ΧΧΧ Χ¤ΧΧ¨ΧΧ ΧΧ¨ΧΧ™ Χ™Χ›Χ•Χ ΧΧ”Χ¤Χ—Χ™Χ Χ§Χ•Χ©Χ™ Χ”Χ›Χ¨Χ•Χ Χ‘Χ ΧΧ™ΧΧ Χ›Χ“Χ•Χ¨Χ™Χ Χ¤Χ•ΧΧ™Χ Χ”ΧΧΆΧ•Χ¨Χ¨Χ Χ‘Χ—Χ™ΧΧ”.
-   Χ™Χ© ΧΧ”Χ™ΧΧ ΧΆ ΧΧΧΧ Χ©Χ ΧΧ¨Χ•Χ¤Χ•Χ ΧΧ ΧΧ™-Χ“Χ•Χ¤ΧΧ™Χ Χ¨Χ’Χ™Χ•Χ Χ‘ΧΧΧ•Χ¤ΧΧ™Χ Χ”Χ΅Χ•Χ‘ΧΧ™Χ ΧΧΧ—ΧΧ Χ¤Χ¨Χ§Χ™Χ Χ΅Χ•Χ.

**Χ”ΧΧΆΧ¨Χ‘Χ•Χ™Χ•Χ ΧΧ ΧΧ¨Χ•Χ¤ΧΧ™Χ•Χ**  
ΧΧΧ¦ΧΆΧ™Χ ΧΧ ΧΧ¨Χ•Χ¤ΧΧ™Χ™Χ Χ”Χ™Χ Χ Χ—Χ©Χ•Χ‘Χ™Χ Χ•Χ™Χ© ΧΧ©Χ§Χ•Χ Χ©Χ™ΧΧ•Χ© Χ‘Χ”Χ ΧΧ¦Χ“ Χ¨Χ™Χ©Χ•Χ ΧΧ¨Χ•Χ¤Χ•Χ Χ Χ•Χ’Χ“Χ•Χ Χ”Χ§ΧΧ”:
-   ΧΧ™Χ¤Χ•Χ Χ¤Χ” Χ§Χ‘Χ•ΧΆ (Χ¨ΧΧ• Χ”Χ Χ—Χ™Χ•Χ ΧΧΧ™Χ¤Χ•Χ Χ¤Χ”)
-   Χ”Χ΅Χ“Χ¨Χ Χ¤ΧΆΧ•ΧΧ ΧΧΆΧ™Χ™Χ. ΧΆΧ¦Χ™Χ¨Χ•Χ ΧΆΧΧ•ΧΧ” ΧΧ”Χ™Χ•Χ Χ΅Χ™Χ‘Χ” Χ©Χ›Χ™Χ—Χ” ΧΧ‘Χ—Χ™ΧΧ”
-   ΧΧ¨Χ•Χ—Χ•Χ Χ”ΧΧ›Χ™ΧΧ•Χ Χ›ΧΧ•Χ™Χ•Χ Χ§ΧΧ Χ•Χ ΧΆΧ“Χ™Χ¤Χ•Χ ΧΧΧ¨Χ•Χ—Χ•Χ Χ’Χ“Χ•ΧΧ•Χ
-   Χ”Χ™ΧΧ ΧΆΧ•Χ ΧΧ”Χ›Χ Χ ΧΧ–Χ•Χ ΧΧ• Χ¨Χ™Χ—Χ•Χ Χ‘Χ™Χ©Χ•Χ
-   ΧΧ•Χ™Χ¨Χ” Χ¨Χ’Χ•ΧΆΧ” Χ•Χ‘ΧΧ•Χ—Χ”
-   Χ©Χ™ΧΧ•Χ© Χ‘Χ¦ΧΧ™Χ“ ΧΧ§Χ•Χ¤Χ¨Χ΅Χ•Χ¨Χ”  (ΧΧ—Χ¥ ΧΆΧ Χ Χ§Χ•Χ“Χ•Χ Χ©Χ Χ“Χ™Χ§Χ•Χ¨ Χ΅Χ™Χ Χ™ ΧΧ”Χ§ΧΧ” ΧΆΧ Χ‘Χ—Χ™ΧΧ•Χ, ΧΧΧ©Χ Seaband)
-   Χ“Χ™Χ§Χ•Χ¨ Χ΅Χ™Χ Χ™ (ΧΧ§Χ•Χ¤Χ Χ§ΧΧ•Χ¨Χ”)
-   Χ’Χ™Χ©Χ•Χ ΧΧ™Χ¤Χ•Χ Χ¤Χ΅Χ™Χ›Χ•ΧΧ•Χ’Χ™Χ•Χ

**ΧΧ™Χ¤Χ•Χ ΧΧ¨Χ•Χ¤ΧΧ™  (<sup>π”―</sup>ΧΧ‘ΧΧ” ΧΧ΅Χ›ΧΧ)**  
Χ›ΧΧΆΧ Χ›Χ Χ’Χ•Χ¨Χ ΧΧ‘Χ—Χ™ΧΧ” ΧΧ• Χ”Χ§ΧΧ” Χ Χ™ΧΧ ΧΧ΅Χ™Χ•Χ•Χ’ Χ‘Χ§ΧΧ’Χ•Χ¨Χ™Χ•Χ Χ©ΧΧ”ΧΧ Χ•Χ‘Χ”ΧΧΧΧ” ΧΧ›Χ ΧΧ•Χ›Χ•Χ•Χ Χ‘Χ—Χ™Χ¨Χ Χ”ΧΧ¨Χ•Χ¤Χ” ΧΧ• Χ§Χ‘Χ•Χ¦Χ Χ”ΧΧ¨Χ•Χ¤Χ•Χ.

 | Χ’Χ•Χ¨Χ |  Χ§Χ‘Χ•Χ¦Χ ΧΧ¨Χ•Χ¤Χ•Χ   |
| -------- | ------- |
| Χ¨ΧΆΧ™ΧΧ•Χ Χ§ΧΧ™Χ Χ™Χ (Χ›Χ•ΧΧ Χ’Χ•Χ¨Χ ΧΧ¨Χ•Χ¤ΧΧ™) ΧΧ• Χ”Χ¤Χ¨ΧΆΧ” ΧΧΧ‘Χ•ΧΧ™Χ /  Χ‘Χ™Χ•Χ›Χ™ΧΧ™Χ  (Χ¨ΧΧ• Χ¤Χ™Χ¨Χ•Χ ΧΧΆΧ™Χ)  | ΧΧ ΧΧ’Χ•Χ Χ™Χ΅ΧΧ™Χ ΧΧ“Χ•Χ¤ΧΧΧ™Χ, ΧΧ“Χ•Χ’ΧΧ:  METOCLOPRAMIDE HALOPERIDOL<sup>QT,OL</sup> LEVOMEPROMAZINE<sup>QT,OL</sup> |
| Χ”Χ¤Χ¨ΧΆΧ•Χ Χ‘Χ Χ™ΧΆ (ΧΧ•ΧΧ™ΧΧ™Χ•Χ) (Χ›Χ•ΧΧ Χ’Χ•Χ¨Χ ΧΧ¨Χ•Χ¤ΧΧ™ Χ•Χ¤Χ’Χ™ΧΆΧ” Χ¤ΧΧ¨ΧΧ ΧΧ•Χ¤ΧΧ΅ΧΧ™Χ) | ΧΧ’Χ‘Χ™Χ¨Χ™ Χ Χ™ΧΆ Prokinetic ΧΧ“Χ•Χ’ΧΧ: METOCLOPRAMIDE (Χ–Χ”Χ™Χ¨Χ•Χ Χ‘Χ©Χ™ΧΧ•Χ© ΧΧΧ•Χ©Χ Χ‘ΧΧ™Χ Χ•Χ Χ™Χ Χ’Χ‘Χ•Χ”Χ™Χ, ΧΧΆΧ§Χ•Χ‘ ΧΧ—Χ¨ ΧΧ•Χ¤ΧΆΧ•Χ ΧΧ•Χ•ΧΧ™ ΧΧ§Χ΅ΧΧ¨ΧΧ¤Χ¨Χ™ΧΧ™Χ“ΧΧ™Χ•Χ), ΧΧ• DOMPERIDONE<sup>QT,OL</sup> |
| Χ”Χ¤Χ¨ΧΆΧ•Χ ΧΧ•Χ Χ’Χ•ΧΧ’ΧΧΧ™Χ•Χ, ΧΧΧ©Χ Χ”Χ¤Χ¨ΧΆΧ” Χ•Χ΅ΧΧ™Χ‘Χ•ΧΧ¨Χ™Χ, Χ‘Χ—Χ™ΧΧ” Χ”Χ§Χ©Χ•Χ¨Χ” ΧΧΧ Χ•ΧΆΧ” | ΧΧ ΧΧ™Χ›Χ•ΧΧ™Χ Χ¨Χ’Χ™Χ•Χ ΧΧ• ΧΧ ΧΧ™-Χ”Χ™Χ΅ΧΧΧ™Χ Χ™Χ  CYCLIZINE  ΧΧ•  HYOSCINE HYDROBROMIDE<sup>OL</sup> CORTICOSTEROID<sup>OL</sup> LEVOMEPROMAZINE<sup>QT,OL</sup> PROCHLORPERAZINE<sup>QT</sup> |
| ΧΧ—Χ¥ ΧΧ•Χ Χ’Χ•ΧΧ’ΧΧΧ™ ΧΧ•Χ’Χ‘Χ¨  | Χ§Χ•Χ¨ΧΧ™Χ§Χ•Χ΅ΧΧ¨Χ•ΧΧ™Χ“Χ™Χ- Χ“Χ§Χ΅ΧΧΧ–Χ•Χ |

 | Χ’Χ•Χ¨Χ |  Χ΅Χ•Χ’ ΧΧ¨Χ•Χ¤Χ”   |
| -------- | ------- |
| Χ’Χ™Χ¨Χ•Χ™ Χ¤Χ” / ΧΧ•ΧΆ / Χ•Χ©Χ | ΧΧ ΧΧ™-Χ›Χ•ΧΧ™Χ Χ¨Χ’Χ™Χ•Χ ΧΧ• ΧΧ ΧΧ™-Χ”Χ™Χ΅ΧΧΧ™Χ Χ™Χ CYCLIZINE  ΧΧ• HYOSCINE<sup>OL</sup> ΧΧ• LEVOMEPROMAZINE<sup>QT,OL</sup> |
| Χ¨Χ‘ Χ΅Χ™Χ‘ΧΧ™ / ΧΧ Χ™Χ“Χ•ΧΆ / Χ¨Χ¤Χ¨Χ§ΧΧ•Χ¨Χ™ | Χ Χ•Χ’Χ“Χ™ Χ”Χ§ΧΧ” Χ‘Χ”ΧΧΧ ΧΧ΅Χ™Χ‘Χ” Χ™Χ“Χ•ΧΆΧ”. ΧΧ• Χ Χ•Χ’Χ“ Χ”Χ§ΧΧ” Χ¨Χ—Χ‘-ΧΧ•Χ•Χ—   LEVOMEPROMAZINE<sup>QT,OL</sup> |
| ΧΧ¨Χ›Χ–Χ™ (Χ›ΧΧ‘ / Χ¤Χ—Χ“ / Χ—Χ¨Χ“Χ”) | ΧΧ™Χ–Χ•Χ Χ›ΧΧ‘, ΧΧ™Χ¤Χ•Χ Χ‘Χ—Χ¨Χ“Χ” |
| Χ‘Χ—Χ™ΧΧ•Χ Χ•Χ”Χ§ΧΧ•Χ Χ‘Χ©Χ ΧΧ™Χ¤Χ•Χ Χ›Χ™ΧΧ•ΧΧ¨Χ¤Χ™ Χ•/ΧΧ• Χ”Χ§Χ¨Χ ΧΧ™  | Χ¤Χ Χ• ΧΧ”Χ Χ—Χ™Χ•Χ ΧΧ§Χ•ΧΧ™Χ•Χ |


## Χ Χ§Χ•Χ“Χ•Χ ΧΧ™Χ™Χ©Χ•Χ
-	ΧΧ Χ΅Χ•Χ ΧΧΧΧ¨ Χ•ΧΧ–Χ”Χ•Χ Χ’Χ•Χ¨ΧΧ™Χ ΧΧ‘Χ—Χ™ΧΧ” Χ•Χ”Χ§ΧΧ” Χ•ΧΧΧ¤Χ Χ‘Χ”ΧΧΧ. 
-	ΧΧ•Χ•Χ“Χ Χ”ΧΧΧΧ” Χ‘Χ™Χ Χ‘Χ—Χ™Χ¨Χ Χ”ΧΧ¨Χ•Χ¤Χ” Χ Χ•Χ’Χ“Χ Χ”Χ”Χ§ΧΧ” ΧΧ’Χ•Χ¨Χ Χ”ΧΧ©Χ•ΧΆΧ¨ Χ•Χ›Χ™ Χ”Χ™Χ Χ Χ™ΧΧ Χ Χ‘Χ¦Χ•Χ¨Χ Χ”ΧΧΧ Χ”ΧΧΧΧ™ΧΧ” Χ‘Χ™Χ•ΧΧ¨. ΧΧ Χ”Χ‘Χ—Χ™ΧΧ•Χ Χ•Χ”Χ”Χ§ΧΧ•Χ Χ ΧΧ©Χ›Χ•Χ, ΧΧ‘Χ¦ΧΆ Χ”ΧΆΧ¨Χ›Χ” ΧΧ—Χ•Χ“Χ©Χ Χ•ΧΧΧ¤Χ Χ‘Χ”ΧΧΧ. ΧΧ ΧΧ™Χ Χ©Χ™Χ¤Χ•Χ¨, ΧΧ”Χ™Χ•Χ•ΧΆΧ¥ ΧΆΧ ΧΧ•ΧΧ—Χ”. 
-	Χ‘Χ”Χ§ΧΧ•Χ ΧΧΧ•Χ©Χ›Χ•Χ, Χ Χ™Χ”Χ•Χ Χ΅ΧΧΧ•Χ΅ Χ”Χ™Χ“Χ¨Χ¦Χ™Χ” Χ•ΧΧ–Χ•Χ Χ” Χ”Χ•Χ Χ—Χ™Χ•Χ Χ™ (Χ¨ΧΧ• Χ”Χ Χ—Χ™Χ•Χ ΧΧΧ ΧΆΧ™Χ¨Χ•Χ™ ΧΧ ΧΆΧ•Χ¨Χ™).
-	ΧΧΧ¨Χ•Χ ΧΧ™Χ¤Χ•Χ ΧΧ•ΧΧΧ, Χ™ΧΧ›Χ Χ©Χ”ΧΧΧ•Χ¤Χ Χ™ΧΧ©Χ™Χ ΧΧ΅Χ‘Χ•Χ ΧΧ”Χ§ΧΧ•Χ, Χ‘ΧΧ™Χ•Χ—Χ“ Χ‘ΧΧ§Χ¨Χ” Χ©Χ Χ—Χ΅Χ™ΧΧ” Χ‘ΧΧ•Χ¦Χ Χ”Χ§Χ™Χ‘Χ” ΧΧ• Χ‘ΧΧ¨Χ™Χ΅Χ¨Χ™Χ•Χ ΧΧ• Χ—Χ΅Χ™ΧΧ ΧΧΆΧ™Χ™Χ ΧΧ—Χ¨Χ. Χ™Χ© ΧΧ–Χ›Χ•Χ¨ ΧΧ©Χ§Χ•Χ ΧΧ¤Χ©Χ¨Χ•Χ Χ–Χ•. (Χ¨ΧΧ• Χ”Χ Χ—Χ™Χ•Χ ΧΧΧ™Χ¤Χ•Χ Χ‘Χ—Χ΅Χ™ΧΧ ΧΧΆΧ™Χ™Χ). 
-	Χ›ΧΧ‘ ΧΆΧ•Χ•Χ™ΧΧ™ Χ‘Χ‘ΧΧ ΧΧΧ—Χ¨ Χ ΧΧ™ΧΧ ΧΧ¨Χ•Χ¤Χ” Χ¤Χ¨Χ•-Χ§Χ™Χ ΧΧ™Χ Χ™Χ›Χ•Χ ΧΧ”Χ—Χ©Χ™Χ“ ΧΧ—Χ΅Χ™ΧΧ ΧΧΆΧ™Χ™Χ.



**ΧΧ§Χ¨Χ**
<sup>OL</sup> Off Label, <sup>QT</sup> Prolongs QT, <sup>π”―</sup>Χ”ΧΆΧ¨Χ•Χ Χ’Χ¨Χ΅Χ” Χ™Χ©Χ¨ΧΧΧ™Χ 


## Χ§Χ™Χ©Χ•Χ¨ ΧΧΧΧ¨ Χ”ΧΧ§Χ•Χ¨Χ™
[Scottish Palliative Care Guidelines - Nausea and vomiting](https://rightdecisions.scot.nhs.uk/scottish-palliative-care-guidelines/symptom-control/nausea-and-vomiting)

## Χ Χ΅Χ¤Χ—Χ™Χ 
[Χ Χ΅Χ¤Χ— A β€“  ΧΧ¨Χ•Χ¤Χ•Χ Χ‘Χ–Χ™Χ§Χ” ΧΧΧΧ¨Χ™ Χ¨Χ¦Χ¤ΧΧ•Χ¨Χ™Χ](https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/nausea-and-vomiting/receptor-site-affinities.aspx)  
  
[Χ Χ΅Χ¤Χ—  B β€“ ΧΧ•Χ— ΧΧΧ¨Χ™ Χ¨Χ¦Χ¤ΧΧ•Χ¨Χ™Χ](https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/nausea-and-vomiting/receptor-site-chart.aspx)
  



## Χ΅Χ™ΧΧ•Χ›Χ™Χ / ΧΧ§Χ•Χ¨Χ•Χ 
Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med. 2001;15(3):247-53  

Clinical Knowledge Summaries. Palliative care - nausea and vomiting. 2016 [cited 2018 Oct 03]; Available from: https://cks.nice.org.uk/palliative-care-nausea-and-vomiting  

Collis E, Mather H. Nausea and vomiting in palliative care. BMJ. 2015;351:h6249  

Cox L, Darvill E, Dorman S. Levomepromazine for nausea and vomiting in palliative care. 2015  Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009420.pub3/abstract  

Dietz I, Schmitz A, Lampey I, Schulz C. Evidence for the use of Levomepromazine for symptom control in the palliative care setting: A systematic review. BMC Palliative Care. 2013;12 (1) (no pagination)(2)  

Gupta M, Davis M, LeGrand S, Walsh D, Lagman R. Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol. J Support Oncol. 2013;11(1):8-13  

Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer. 2004;12(6):432-40  

Kennett A, Hardy J, Shah S, A'Hern R. An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2005;13(9):715-21  

Mannix K. Palliation of nausea and vomiting. CME Cancer Medicine. 2002;1:18-22  

Murray-Brown F, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. 2015Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006271.pub3/abstract  

Prommer E. Role of haloperidol in palliative medicine: an update. The American journal of hospice & palliative care. 2012;29(4):295-301. Epub 2011/10/15  

Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2006;14(4):348-53  

Storrar J, Hitchens M, Platt T, Dorman S. Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews. 2014;11:CD006938  

Wood GJ, Shega JW, Lynch B, Von Roenn JH. Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working". JAMA. 2007;298(10):1196-207
